Hilton Singapore Orchard • Singapore • July 12-14, 2027
July 12–14, 2027

NEURO-LOGIC 2027

The Precision Neuroscience Business Summit

A global executive summit focused on the commercialization, regulation, infrastructure, and investment landscape driving the future of precision neuroscience and Neuro-AI markets.

Who You'll Meet

Pharma Leaders
Institutional Investors
Neuro-AI Founders
Healthcare Regulators
AI Infrastructure Executives
Invitation-Based Access APAC Edition • Hilton Singapore Orchard
Early bird registration open Save with early bird pricing until Oct 2 NEURO-LOGIC 2027 · Hilton Singapore Orchard · July 12–14, 2027 Executive access for neurotechnology, AI healthcare, pharma, investors & commercialization leaders Register now →
Speaker faculty update PS Pawel Swieboda NeuroCentury & Brain Capital Alliance Ryota Kanai Ryota Kanai Araya, Inc. Maro Machizawa Maro Machizawa Xiberlinc Allan McCay Allan McCay The University of Sydney Marcello Ienca Marcello Ienca Technical University of Munich View speakers →

The Precision Neuroscience Business Summit

Sachin Sravan SS

Sachin Sravan

Director of Strategy & Curation, NEURO-LOGIC 2027 LinkedIn Profile
Narendra Etkela NE

Narendra Etkela

Strategic Partnerships & Executive Engagement Associate LinkedIn Profile

NEURO-LOGIC 2027 is a commercial forum at the intersection of computational neuroscience, brain-computer interfaces (BCI), and global capital. As the flagship event in the Synerg Events portfolio, it serves as the critical bridge between cutting-edge “mind-machine” innovation and scalable clinical and pharmaceutical deployment.

In a market where neurotechnology and AI-driven brain health solutions are poised for explosive growth, NEURO-LOGIC 2027 focuses exclusively on commercialization, regulation, investment, and scaling. We move decisively beyond scientific discovery to the practical realities of deal-making, regulatory pathways, reimbursement strategies, and go-to-market execution, accelerating the partnerships and capital flows that will shape the next decade of precision brain health.

This is not another academic conference. It is a tightly curated business summit engineered for senior decision-makers who are actively deploying capital, acquiring technologies, and bringing neuro-AI solutions to market.

EXECUTIVE PARTICIPATION

Built for strategic conversations, institutional partnerships, and commercial growth.

Why Attend

Exclusive Access

Network with a strictly capped audience of 250–300 C-level executives, investors, and innovators.

Actionable Intelligence

Receive direct insight into pharmaceutical M&A pipelines, VC investment priorities, and emerging Neuro-AI commercialization trends.

Regulatory Dialogue

Engage with policymakers and regulators shaping AI-driven neurotechnology, SaMD frameworks, and neural privacy standards.

Curated Deal Flow

Access pre-vetted startups positioned for Series A–C investment, strategic partnerships, and acquisition opportunities.

Who Attends

C-Suite Executives and Founders from high-growth Neuro-AI, BCI, and digital neurology companies.

Heads of R&D, Innovation, Business Development, and M&A from leading global pharmaceutical firms.

Venture Capital, Private Equity, Corporate Venture, and Sovereign Wealth Fund investors.

Technology leaders across AI infrastructure, hyperscalers, neuro-hardware, and cloud platforms.

Regulators, policymakers, and bioethics experts from APAC, Europe, and North America.

SUMMIT PROGRAM

Three days focused on commercialization, regulation, investment, and precision neuroscience growth.

Monday, July 12, 2027

The Data Economy

AI Infrastructure, Digital Biomarkers & Neural Data Systems
Opening Keynote: The $100B Neuro-AI Shift How precision neuroscience is reshaping pharmaceuticals, diagnostics, and cognitive healthcare markets.
Digital Biomarkers & Predictive Neurology Commercializing wearable, behavioral, and ambient health data for next-generation diagnostics.
Neural Data Governance Building global compliance frameworks for cognitive and behavioural data systems.
Scaling Infrastructure for Neuro-AI Platforms Compute, cloud architecture, and enterprise systems powering real-time neural intelligence.
The Race for the Neural Operating System Will Big Tech become the next dominant force in brain-health infrastructure?
Opening Gala Reception An executive reception to open the summit and connect senior delegates.

Wednesday, July 14, 2027

Market Access & Global Scale

Regulation, Reimbursement & International Expansion
Morning Keynote: The Regulatory Bridge Aligning FDA, HSA, EMA, and APAC frameworks for AI-driven healthcare technologies.
The Global Reimbursement Challenge Convincing insurers and healthcare systems to fund digital brain-health interventions.
APAC Neurotech Market Access Launching into Japan, China, Australia, and ASEAN healthcare markets.
The 2030 Precision Clinic Integrating AI, genomics, neurotech, and predictive diagnostics into mainstream healthcare systems.
Summit Closing Ceremony Closing reflections and next steps for the NEURO-LOGIC community.

CONFIRMED FACULTY

Meet the minds moving precision neuroscience forward.

NEURO-LOGIC brings together neuroscience, AI, clinical development, policy, and investment leaders who are shaping how brain-health innovation reaches patients.

Apply to speak
Faculty announcements

New speakers will be announced progressively.

We are curating a cross-disciplinary faculty from biopharma, neurotechnology, AI, academia, policy, and capital.

Apply to Speak

CONFIRMED VENUE

Hilton Singapore Orchard

NEURO-LOGIC 2027 will take place at Hilton Singapore Orchard, bringing the precision neuroscience community together in the heart of Singapore's Orchard Road district. Delegate accommodation and arrival guidance will be shared with registered attendees.

DatesJuly 12–14, 2027
VenueHilton Singapore Orchard
Address333 Orchard Road
Singapore 238867